Defining Therapeutic Sensitivity of Patient-Derived Cancer Organoids in Cholangiocarcinoma

Candidate: I am a staff medical oncologist at the William S. Middleton Memorial Veterans Hospital and Assistant Professor of Medicine at the University of Wisconsin School of Medicine and Public Health. I obtained my MD from the University of Michigan and American Board of Internal Medicine research fast track in internal medicine

and medical oncology at the University of Wisconsin. I completed my post-doctoral training with Dr. Dustin Deming to study mechanisms of targeted therapeutic resistance in colorectal cancer organoid models. I currently serve as subject matter expert in gastrointestinal cancers with the VA National Precision Oncology Program. My

goal is to develop an independent research program specific to hepatobiliary cancers to improve the health outcomes of Veterans through precision applications informed from organotypic models. I was recruited to the William S. Middleton Memorial Veterans Hospital and the University of Wisconsin with support of clinical and

research efforts dedicated to building our research program through institutional mentorship, laboratory resources, and start-up funding. Research Project: Cholangiocarcinoma (CCA) represents a leading cause cancer-related mortality with 5-year survival estimated